Created at 1:04 a.m. Mar, 29, 2025
Author: yelbardisi
Co-authors: FrozenCherry
Related Note: 1463172319857 2
Rationale for change

Should keep treatment options clear about patient population, has been tested in step 2 - gives more context especially because GnRH agonists are not first line for adenomyosis as medical management.

Source: https://next.amboss.com/us/article/tE0Xx3?q=adenomyosis

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
OME
Empty field
Additional Resources
One by one
Empty field
#AK_Step1_v12::#Pathoma::13_Female::04_Endometrium_&_Myometrium #AK_Step1_v12::^Systems::Reproductive::Pathology #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Reproductive::Reproductive_Pathology #PANCE::REPRODUCTIVE::bleeding_disorders #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Other::Only_Step_1 #AK_Step1_v12::#UWorld::COMLEX::25066 #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::05_Sex_Hormones::02_LHRH_agonists_GnRH_analogs #AK_Step1_v12::#OME_banner #AK_Other::AnKing_Image::!Subjects::Reproductive::Adenomyosis #AK_Step1_v12::#UWorld::Step::1957 #AK_Step1_v12::#FirstAid::15_Repro::04_Pathology::29_Uterine_conditions::*Non-Neoplastic::Endometriosis #AK_Step2_v12::#SketchyOBGYN::05_Benign_Gynecology_&_Urogynecology::02_Abnormal_Uterine_Bleeding_&_Pelvic_Pain::02_Endometriosis #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Other::AnKing_Image::AhmedA::Adenomyosis #AK_Step1_v12::#Bootcamp::Reproduction::04_Female_Pathology::05_Adenomyosis,_Endometrial_Hyperplasia,_and_Asherman_Syndrome #AK_Step2_v12::#B&B::11_Obstetrics_and_Gynecology::02_Gynecology::05_Dysmenorrhea::Extra #AK_Step1_v12::#Physeo::11_Pathology::09_Reproductive_Pathology::12_Myometrium #PANCE::EOR::WOMENS_HEALTH #AK_Step1_v12::#Textbooks::#Golan_Pharmacology::30_Pharmacology_Of_Reproduction